ARCHIVES

Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds

This article is from The Cancer Letter archive.

Vol. 30 No. 4 | April 27, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

July 28, 1989

Racial Disparities Remain In Breast Cancer Care

October 29, 2010

OMB Specifies One Year Only Funding for 200 grants Under Supplemental Appropriations Level of 6,200

September 6, 1985

Kimmel Foundation To Donate $1 million for Cancer Research

June 28, 1996

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

NCI Bypass Budget Calls For $5.98 Billion

December 6, 2002